Search results
Weight loss drug wins 25,000 new US users a week
BBC via Yahoo Finance· 16 hours agoThe surge reflects scorching demand for the medicine which, alongside sister diabetes drug Ozempic, has been hailed as revolutionary and helped to...
Novo Nordisk’s Wegovy Sales More Than Doubled. Why the Stock Is Falling.
Barrons.com· 15 hours agoSales of the drug were 9.4 billion Danish kroner ($1.4 billion), more than double the total from the...
Novo Nordisk beats profit estimates as sales of weight loss drug Wegovy more than double
CNBC· 1 day agoDanish pharmaceutical giant Novo Nordisk, which became the most valuable company in Europe last year...
Europe’s AI Paradox: Slow Adoption, Big Ambitions
PYMNTS.com· 19 hours agoDespite Europe’s reputation as a tech laggard, a cadre of companies is making big bets on artificial intelligence (AI). While the region has been slow to...
Weight-loss drug maker Novo Nordisk's profits soar further
AFP via Yahoo Finance· 23 hours agoDanish pharmaceutical giant Novo Nordisk reported more soaring profits on Thursday thanks to the...
Europe’s Biggest Smart City Rises in Greece
Bloomberg via Yahoo Finance· 2 days ago...On the southern coastline of Greece’s capital, a long-awaited plan to transform the city’s former airport into the largest smart city in Europe is...
Novo Nordisk, ING, Shell: European Stocks in the Spotlight
The Wall Street Journal· 16 hours ago↘️ **Novo Nordisk (DK: NOVO.B**, **NVO)**: Europe's most valuable company raised its annual guidance...
How Balkan gangsters became Europe’s top cocaine suppliers
Reuters· 21 hours agoIn 2018, convicted cocaine trafficker Slobodan Kostovski fled a Brazilian prison and made his way...
Novo Nordisk ups guidance buts cuts Wegovy price
Proactive Investors· 23 hours agoNovo Nordisk (NYSE:NVO), Europe's biggest company, said it is ramping up production of its diabtes/weightloss drugs Wegovy and Ozempic, after patient...
Novo Nordisk trims price for blockbuster obesity drug as competition heats up
Reuters· 8 hours ago, opens new tab raised its 2024 outlook on Thursday as the Danish drugmaker races to boost output of...